Biolase Inc Reports Results For The Quarter Ended In December: Earnings Summary

November 26

21/03/2024 23:18

* BIOLASE Inc  BIOL.OQ  reported a quarterly adjusted loss
of
$1.76​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of
$-128.00.  The mean expectation of three analysts for the
quarter was for a loss of $2.55 per share. Wall Street expected
results to range from $-3.31 to $-1.80 per share.
    * Revenue fell 4% to $13.49 million from a year ago;
analysts
expected $13.55 million. 
    * BIOLASE Inc's reported EPS for the quarter was a loss of
$1.76​.
    * The company reported a quarterly loss of $5.33 million.
    * BIOLASE Inc shares had fallen by 86.7% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 9.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for BIOLASE Inc is
$8.75 
This summary was machine generated from LSEG data March 21 at
11:17 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -2.55          -1.76          Beat
 Sep. 30 2023      -1.85          -3.89          Missed
 Jun. 30 2023      -5.33          -8.24          Missed
 Mar. 31 2023      -19.67         -18.00         Beat